By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


LEO Pharma 

Industriparken 55
DK-2750 Ballerup
Copenhagen      Denmark
Phone: 45-4492-3800 Fax: 45-4494-3040



Company News
China's HitGen To Discover Lead Molecules For LEO Pharma Of Denmark 8/8/2017 10:15:44 AM
HitGen And LEO Pharma Enter Research Collaboration 8/7/2017 6:30:53 AM
LEO Pharma Receives Marketing Authorisation For Kyntheum (Brodalumab), A New Biologic For The Treatment Of Moderate-To-Severe Plaque Psoriasis In The European Union 7/20/2017 7:35:56 AM
LEO Pharma Appoints Chris Posner To Lead US Business 6/23/2017 9:53:43 AM
Argenx Receives Second Preclinical Milestone Payment In Collaboration With LEO Pharma 6/20/2017 10:23:50 AM
LEO Pharma Starts Phase III Clinical Study For Tralokinumab In Atopic Dermatitis 6/15/2017 7:39:18 AM
Almirall And LEO Pharma Join Forces To Advance Dermatology Research By Setting A New Standard 5/31/2017 1:21:37 PM
LEO Pharma U.S. Welcomes Judit H. Nyirady As Vice President Of Medical Strategy & Scientific Affairs 5/4/2017 9:28:59 AM
Klox Technologies And LEO Pharma Set Up Company For Biophotonic In Dermatology 3/6/2017 10:16:13 AM
LEO Pharma Announces Positive Results From Phase 2b Clinical Study For Tralokinumab In Atopic Dermatitis 3/3/2017 6:58:33 AM